Tumorigenesis Driven by BRAFV600E Requires Secondary Mutations That Overcome Its Feedback Inhibition of RAC1 and Migration. Gadal S, Boyer JA, Roy SF, Outmezguine NA, et al. Cancer Res 2025;85:1611-1627.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Gadal S, Boyer JA, Roy SF, Outmezguine NA, et al. Tumorigenesis Driven by BRAFV600E Requires Secondary Mutations That Overcome Its Feedback Inhibition of RAC1 and Migration. Cancer Res 2025;85:1611-1627.
PMID: 39992718